33: Troll of Transplantation Part 1
Febrile
00:00
C M B C - Is There a Future?
i warner: There is always some exciting news in the transplant idea world, and you alluded to a little bit of this earlier. The approval of maribyv for refractory resistant postanspan c m v. And since then, by weekly monitoring for c m b, did not show any recurrent viremia. His monitoring was then discontinued after two months. So over all, a good outcome to end the episode.
Transcript
Play full episode
